# FabricNano

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fabricnano

- Industry: Biotechnology
- Headquarters: London, UK
- Website: www.fabricnano.com
- Total disclosed funding: $16M
- Latest round: Series A (Jun 30, 2021)
- Investors on record: 4

## About

Based in the UK, FabricNano Limited specializes in advanced biotechnology solutions, particularly in the production of synthetic biology applications through innovative biomanufacturing techniques.FabricNano Limited, founded in 2018 and headquartered in London, UK, focuses on developing cutting-edge biomanufacturing solutions. The company has not undergone any significant pivots and is led by CEO Grant Aarons, who is also the founder. FabricNano has completed a total of 3 funding rounds, with the most recent being a Series A round on June 30, 2021, where they raised GBP 9 million, led by Atomico, along with participation from Backed VC, Hoxton Ventures, and Entrepreneur First. The total amount raised by the company amounts to GBP 9 million.FabricNano specializes in developing advanced biotechnology solutions aimed at transforming the production and application of synthetic biology. Their core offerings include innovative biomanufacturing platforms that utilize engineered microorganisms to produce high-value compounds for diverse industries, including pharmaceuticals, agriculture, and specialty chemicals. These systems are designed to enhance the efficiency and sustainability of manufacturing processes, addressing critical challenges such as resource scarcity and environmental impact. FabricNano serves a varied clientele that includes research institutions, biopharmaceutical companies, and agricultural firms across North America and Europe. Their products have been instrumental in streamlining production workflows and reducing costs, making them valuable assets in the rapidly evolving biotechnology landscape.FabricNano generates revenue primarily through direct partnerships and collaborations with industry players and research institutions. Their business model often involves strategic alliances where they provide biomanufacturing solutions tailored to the specific needs of their partners, fostering long-term relationships. Revenue may be derived from project-based fees, licensing agreements, and potential royalties associated with the sale of produced compounds. The company’s flagship products, such as their proprietary biomanufacturing platform, are positioned to command premium pricing due to their advanced capabilities and the value they deliver to end-users. These structured transactions allow FabricNano to engage deeply with clients, ensuring that their offerings meet the evolving demands of the biotechnology sector while promoting sustainable practices.In June 2021, FabricNano Limited raised GBP 9 million in Series A funding to advance the development of sustainably synthesized alternatives to petrochemical products and drugs, which currently account for 14% of global oil demand. The company is focused on designing and launching new biomanufacturing products that will enhance the production efficiency for its customers. Additionally, FabricNano plans to expand its market presence into North America and Europe by 2023, leveraging the recent funding to support these initiatives.

## Funding rounds

- Series A, Jun 30, 2021, $13M — Atomico, Hoxton Ventures, Entrepreneur First, Backed VC
- Seed, Jul 2, 2019, $3.2M — Hoxton Ventures, Entrepreneur First, Backed VC

## Investors

- Hoxton Ventures (https://capitalatlas.ai/funds/hoxton-ventures) — Seed, Series A
- Entrepreneur First (https://capitalatlas.ai/funds/entrepreneur-first) — Seed, Series A
- Backed VC (https://capitalatlas.ai/funds/backed-vc) — Seed, Series A
- Atomico (https://capitalatlas.ai/funds/atomico) — Series A